Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required